Ecalectin/galectin-9, a novel eosinophil chemoattractant: Its function and production

被引:47
|
作者
Hirashima, M [1 ]
机构
[1] Kagawa Med Sch, Dept Immunol & Immunopathol, Kagawa 76107, Japan
关键词
ecalectin; galectin; eosinophil; chemoattraction; regulation;
D O I
10.1159/000053623
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We have recently succeeded in purifying and cloning a novel eosinophil chemoattractant, ecalectin/galectin-9, which belong to a rapidly growing galectin family. The eosinophil chemoattractant activity of ecalectin is potent and selective for eosinophils. The cellular source of ecalectin has been thought to be antigen-stimulated T cells. Herein, we will review the significance of its divalent galactoside-binding activity in ecalectin-induced eosinophil chemoattraction and the regulation of ecalectin expression in immune cells. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [1] Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes
    Matsumoto, R
    Matsumoto, H
    Seki, M
    Hata, M
    Asano, Y
    Kanegasaki, S
    Stevens, RL
    Hirashima, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 16976 - 16984
  • [2] High expression of eosinophil chemoattractant ecalectin/galectin-9 in drug-induced liver injury
    Takahashi, Y
    Fukusato, T
    Kobayashi, Y
    Akiyama, S
    Tamatani, T
    Shiga, J
    Mori, S
    LIVER INTERNATIONAL, 2006, 26 (01) : 106 - 115
  • [3] Human ecalectin, a variant of galectin-9, is a novel eosinophil chemoattractant produced by antigen-activated T lymphocytes.
    Matsumoto, R
    Matsumoto, H
    Seki, M
    Hata, M
    Asano, Y
    Kanegasaki, S
    Stevens, RL
    Hirashima, M
    FASEB JOURNAL, 1998, 12 (05): : A943 - A943
  • [4] Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction
    Matsushita, N
    Nishi, N
    Seki, M
    Matsumoto, R
    Kuwabara, I
    Liu, FT
    Hata, Y
    Nakamura, T
    Hirashima, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 8355 - 8360
  • [5] Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps
    Iino, Y
    Miyazawa, T
    Kakizaki, K
    Saigusa, H
    Katano, H
    Shiga, J
    Kanegasaki, S
    ACTA OTO-LARYNGOLOGICA, 2006, 126 (01) : 43 - 50
  • [6] Association of galectin-9 with eosinophil apoptosis
    Saita, N
    Goto, E
    Yamamoto, T
    Cho, I
    Tsumori, K
    Kohrogi, H
    Maruo, K
    Ono, T
    Takeya, M
    Kashio, Y
    Nakamura, K
    Hirashima, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 128 (01) : 42 - 50
  • [7] Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity
    Sato, M
    Nishi, N
    Shoji, H
    Seki, M
    Hashidate, T
    Hirabayashi, J
    Kasai, K
    Hata, Y
    Suzuki, S
    Hirashima, M
    Nakamura, T
    GLYCOBIOLOGY, 2002, 12 (03) : 191 - 197
  • [8] Galectin-9 Changes Its Function to Maintain Homeostasis
    Hirashima, Mitsuomi
    Niki, Toshiro
    Masaki, Tsutomu
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2018, 30 (172) : SJ55 - SJ64
  • [9] Gene expression of galectin-9/ecalectin, a potent eosinophil chemoattractant, and/or the insertional isoform in human colorectal carcinoma cell lines and detection of frame-shift mutations for protein sequence truncations in the second functional lectin domain
    Lahm, H
    Hoeflich, A
    André, S
    Sordat, B
    Kaltner, H
    Wolf, E
    Gabius, HJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (03) : 519 - 524
  • [10] Galectin-8 and galectin-9 are novel substrates for thrombin
    Nishi, Nozomu
    Itoh, Aiko
    Shoji, Hiroki
    Miyanaka, Hiroshi
    Nakamura, Takanori
    GLYCOBIOLOGY, 2006, 16 (11) : 15C - 20C